Equities

Artivion Inc

Artivion Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)28.71
  • Today's Change-0.270 / -0.93%
  • Shares traded370.09k
  • 1 Year change+108.65%
  • Beta1.7444
Data delayed at least 15 minutes, as of Nov 08 2024 21:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.

  • Revenue in USD (TTM)376.97m
  • Net income in USD-8.32m
  • Incorporated2022
  • Employees1.50k
  • Location
    Artivion Inc1655 Roberts Boulevard N WKENNESAW 30144United StatesUSA
  • Phone+1 (770) 419-3355
  • Fax+1 (770) 426-0031
  • Websitehttps://artivion.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Embecta Corp1.12bn69.70m896.69m2.20k12.88--8.280.80141.211.2119.36-13.240.88822.1111.60508,590.905.53--7.91--66.42--6.23--1.612.061.88---0.7703---68.52------
Cytek Biosciences Inc201.21m-10.16m927.11m645.00--2.37--4.61-0.0782-0.07821.522.970.39821.603.72297,647.90-2.01---2.29--54.92---5.05--5.47--0.0032--17.67---571.58------
Castle Biosciences Inc311.88m6.08m932.36m610.00166.522.1147.742.990.19990.199911.0715.770.65629.157.15511,275.401.28-9.431.40-10.1781.9080.581.95-28.467.64--0.0228--60.3857.3514.41--117.94--
Avanos Medical Inc681.50m21.70m937.98m3.77k43.620.762713.881.380.46790.338514.7026.760.40311.905.16180,721.301.28-0.65271.45-0.733855.5154.453.18-1.601.469.840.1164---1.580.6357-146.05---18.37--
Bioventus Inc536.89m-41.96m959.25m1.03k--6.34--1.79-0.6595-0.65958.481.860.65911.954.18553,495.90-6.70-5.52-9.65-7.2766.5368.25-10.16-10.940.9561.080.6697--0.04459.936.91--23.51--
Owens & Minor, Inc.10.66bn-48.79m994.71m13.70k--1.144.490.0933-0.6346-0.6346139.2711.352.097.2615.86778,172.30-0.95611.32-1.492.0720.7216.48-0.45760.56140.45192.030.68310.7983.801.87-284.47--25.91--
CeriBell Inc-100.00bn-100.00bn1.01bn----------------0.5919------------------------3.53--0.4912--74.47--20.72------
Artivion Inc376.97m-8.32m1.20bn1.50k--4.0780.133.19-0.2076-0.20769.117.060.4811.675.44251,316.00-1.07-2.20-1.15-2.3664.6365.51-2.22-5.344.041.070.5177--12.826.14-60.09--5.13--
BioLife Solutions Inc121.17m-53.87m1.21bn409.00--3.75--9.95-1.21-1.642.696.970.29991.995.39296,254.30-13.33-13.76-14.60-15.0441.2736.76-44.46-42.991.81-5.980.0651---11.4348.6552.49--86.35--
Pulse Biosciences Inc0.00-46.13m1.22bn56.00--15.45-----0.8069-0.80690.001.290.00----0.00-58.03-93.21-62.84-104.99-------12,332.25----0.00---100.00--27.85---15.20--
Establishment Labs Holdings Inc151.35m-83.20m1.29bn857.00--28.71--8.54-3.11-3.115.621.610.53070.85252.72166,685.00-29.17-33.22-34.29-41.1266.0464.73-54.97-43.192.91-20.680.8114--2.1321.96-4.38--69.16--
Alphatec Holdings Inc572.74m-177.87m1.33bn839.00------2.33-1.27-1.274.080.15460.80891.117.73682,644.80-25.12-30.97-32.00-39.4769.4766.02-31.06-46.221.15-3.660.9596--37.4539.38-23.36--67.92--
Adapthealth Corp3.26bn-217.76m1.36bn10.70k--0.89538.240.4161-1.64-1.6424.2311.270.709621.158.45304,912.50-4.57-4.34-5.14-4.8919.0318.28-6.44-6.470.99512.290.5757--7.73---1,169.99------
STAAR Surgical Co341.22m21.78m1.46bn1.06k67.543.4152.714.270.43810.43816.908.690.67632.033.15323,128.804.326.774.927.9078.7376.896.389.165.38--0.00020.0013.3721.07-46.1833.8551.95--
Inmode Ltd423.75m153.67m1.48bn581.0010.512.189.593.491.851.855.048.920.52391.5810.15729,339.1019.0031.3220.7735.6481.6484.4636.2639.659.91--0.000.008.3237.4922.5454.6513.10--
Data as of Nov 08 2024. Currency figures normalised to Artivion Inc's reporting currency: US Dollar USD

Institutional shareholders

57.81%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Jun 20246.06m14.47%
Macquarie Investment Management Business Trustas of 30 Jun 20242.81m6.71%
Perceptive Advisors LLCas of 30 Jun 20242.79m6.67%
The Vanguard Group, Inc.as of 30 Jun 20242.67m6.38%
Juniper Investment Co. LLCas of 30 Jun 20242.10m5.01%
Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Jun 20242.03m4.85%
Wellington Management Co. LLPas of 30 Sep 20241.66m3.95%
SSgA Funds Management, Inc.as of 30 Jun 20241.52m3.62%
Dimensional Fund Advisors LPas of 30 Sep 20241.44m3.44%
GW&K Investment Management LLCas of 30 Sep 20241.14m2.71%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.